Evidence map›Paper›PMID 33209117›Full record

ReviewEcancermedicalscience2020

Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer.

Renata D'Alpino Peixoto, Duilio R Rocha-Filho, Rui F Weschenfelder, Juliana F M Rego, Rachel Riechelmann, Anelisa K Coutinho, Gustavo S Fernandes, Alexandre A Jacome, Aline C Andrade, Andre M Murad and 40 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Gastric cancer: an overview.Revista da Associacao Medica Brasileira (1992) · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Renata D'Alpino PeixotoGrupo Oncoclínicas, Brazil, 04543-906.
Duilio R Rocha-FilhoRede D'Or, Brazil, 04535-110.
Rui F WeschenfelderHospital Moinhos de Vento, Porto Alegre, Brazil, 90035-000.
Juliana F M RegoHospital Universitário Onofre Lopes, Natal, Brazil, 59012-300.
Rachel RiechelmannAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Anelisa K CoutinhoClínica AMO, Salvador, Brazil, 41.950-640.
Gustavo S FernandesHospital Sírio Libanês, Brazil, 01308-050.
Alexandre A JacomeGrupo Oncoclínicas, Brazil, 04543-906.
Aline C AndradeGrupo Oncoclínicas, Brazil, 04543-906.
Andre M MuradLaboratório Personal, Belo Horizonte, Brazil.
Celso A L MelloAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Diego S C G MiguelClínica AMO, Salvador, Brazil, 41.950-640.
Diogo B D GomesHospital Israelita Albert Einstein, São Paulo. Brazil, 05652- 900.
Douglas J RacyHospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil, 01323-001.
Eduardo D MoraesGrupo Oncoclínicas, Brazil, 04543-906.
Eduardo H AkaishiFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Elisangela S CarvalhoHospital São Rafael, Salvador, Brazil, 41253-190.
Evandro S MelloFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Fauze Maluf FilhoFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Felipe J F CoimbraAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Fernanda C CapareliHospital Sírio Libanês, Brazil, 01308-050.
Fernando F ArrudaHospital Sírio Libanês, Brazil, 01308-050.
Fernando M A C VieiraAméricas Oncologia, Brazil, 22775-001.
Flavio R TakedaFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Guilherme C C CottiHospital Sírio Libanês, Brazil, 01308-050.
Guilherme L S PereiraCentro de Oncologia do Paraná, Curitiba, Brazil, 81200-100.
Gustavo A PauloUniversidade Federal de São Paulo, São Paulo, Brazil, 04040-003.
Héber S C RibeiroAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Laercio G LourencoUniversidade Federal de São Paulo, São Paulo, Brazil, 04040-003.
Marcela CrosaraHospital Sírio Libanês, Brazil, 01308-050.
Marcelo G TonetoHospital São Lucas da PUCRS, Porto Alegre, Brazil, 90610-000.
Marcos B OliveiraFaculdade de Ciências Médicas da Santa Casa de São Paulo, Sâo Paulo, Brazil, 01238-010.
Maria de Lourdes OliveiraRede D'Or, Brazil, 04535-110.
Maria Dirlei BegnamiAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Nora M ForonesUniversidade Federal de São Paulo, São Paulo, Brazil, 04040-003.
Osmar YagiFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Patricia Ashton-ProllaHospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, 90035-903.
Patricia B AguillarHospital Alemão Oswaldo Cruz, São Paulo, Brazil, 01323-020.
Paulo C G AmaralClínica AMO, Salvador, Brazil, 41.950-640.
Paulo M HoffRede D'Or, Brazil, 04535-110.
Raphael L C AraujoUniversidade Federal de São Paulo, São Paulo, Brazil, 04040-003.
Raphael P Di Paula FilhoHospital Alemão Oswaldo Cruz, São Paulo, Brazil, 01323-020.
Rene C GanslGrupo Oncoclínicas, Brazil, 04543-906.
Roberto A GilGrupo Oncoclínicas, Brazil, 04543-906.
Tulio E F PfifferHospital Sírio Libanês, Brazil, 01308-050.
Tulio SouzaHospital Aliança de Salvador, Salvador, Brazil, 41920-900.
Ulysses RibeiroFaculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 01246903.
Victor Hugo F JesusAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Wilson L CostaAC Camargo Cancer Center, São Paulo, Brazil, 01525-001.
Gabriel ProllaGrupo Oncoclínicas, Brazil, 04543-906.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is among the ten most common types of cancer worldwide. Most cases and deaths related to the disease occur in developing countries. Local socio-economic, epidemiologic and healthcare particularities led us to create a Brazilian guideline for the management of gastric carcinomas. The Brazilian Group of Gastrointestinal Tumors (GTG) invited 50 physicians with different backgrounds, including radiology, pathology, endoscopy, nuclear medicine, genetics, oncological surgery, radiotherapy and clinical oncology, to collaborate. This document was prepared based on an extensive review of topics related to heredity, diagnosis, staging, pathology, endoscopy, surgery, radiation, systemic therapy and follow-up, which was followed by presentation, discussion, and voting by the panel members. It provides updated evidence-based recommendations to guide clinical management of gastric carcinomas in several scenarios and clinical settings.

Indexed as

gastric cancergastroesophageal cancerguidelines

Identifiers

PMID33209117
PMCPMC7652540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.